ImmunoCellular Therapeutics Price History

IMUCDelisted Stock  USD 0.47  0.00  0.00%   
If you're considering investing in ImmunoCellular Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of ImmunoCellular Therapeutics stands at 0.47, as last reported on the 14th of December 2024, with the highest price reaching 0.47 and the lowest price hitting 0.47 during the day. We have found eighteen technical indicators for ImmunoCellular Therapeutics, which you can use to evaluate the volatility of the firm. Please check out ImmunoCellular Therapeutics' Standard Deviation of 11.82, risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.21) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
ImmunoCellular Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
IMUC
Based on monthly moving average ImmunoCellular Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ImmunoCellular Therapeutics by adding ImmunoCellular Therapeutics to a well-diversified portfolio.

ImmunoCellular Therapeutics Pink Sheet Price History Chart

There are several ways to analyze ImmunoCellular Stock price data. The simplest method is using a basic ImmunoCellular candlestick price chart, which shows ImmunoCellular Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

ImmunoCellular Pink Sheet Price History Data

The price series of ImmunoCellular Therapeutics for the period between Sun, Sep 15, 2024 and Sat, Dec 14, 2024 has a statistical range of 0.48 with a coefficient of variation of 19.41. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.7. The median price for the last 90 days is 0.71. The company completed 1:10 stock split on 16th of September 2020. ImmunoCellular Therapeutics completed dividends distribution on 2020-09-16.
OpenHighLowCloseVolume
12/14/2024
 0.47  0.47  0.47  0.47 
02/08/2023 0.47  0.47  0.47  0.47  600.00 
02/07/2023 0.51  0.51  0.47  0.50  3,320 
02/06/2023 0.58  0.58  0.47  0.53  606.00 
02/03/2023 0.60  0.62  0.59  0.59  1,334 
02/02/2023 0.61  0.61  0.61  0.61  179.00 
02/01/2023 0.62  0.62  0.62  0.62  100.00 
01/31/2023 0.62  0.62  0.62  0.62  1.00 
01/30/2023 0.62  0.62  0.62  0.62  1.00 
01/27/2023 0.43  0.62  0.43  0.62  200.00 
01/26/2023 0.62  0.62  0.62  0.62  5,000 
01/25/2023 0.64  0.64  0.64  0.64  1.00 
01/24/2023 0.55  0.65  0.55  0.64  1,900 
01/23/2023 0.46  0.65  0.46  0.46  11,200 
01/20/2023 0.53  0.53  0.53  0.53  600.00 
01/19/2023 0.55  0.55  0.55  0.55  1.00 
01/18/2023 0.52  0.55  0.46  0.55  2,000 
01/17/2023 0.55  0.55  0.55  0.55  400.00 
01/13/2023 0.55  0.55  0.51  0.51  7,600 
01/12/2023 0.60  0.60  0.60  0.60  99.00 
01/11/2023 0.77  0.77  0.57  0.60  9,675 
01/10/2023 0.61  0.61  0.61  0.61  503.00 
01/09/2023 0.71  0.71  0.71  0.71  41.00 
01/06/2023 0.71  0.71  0.71  0.71  300.00 
01/05/2023 0.80  0.80  0.80  0.80  23.00 
01/04/2023 0.60  0.80  0.60  0.80  2,543 
01/03/2023 0.73  0.80  0.59  0.59  9,128 
12/30/2022 0.59  0.93  0.59  0.82  7,107 
12/29/2022 0.62  0.63  0.62  0.63  3,534 
12/28/2022 0.69  0.69  0.62  0.66  10,114 
12/27/2022 0.78  0.78  0.70  0.70  23,040 
12/23/2022 0.78  0.84  0.71  0.84  5,200 
12/22/2022 0.71  0.71  0.71  0.71  700.00 
12/21/2022 0.79  0.79  0.79  0.79  15.00 
12/20/2022 0.79  0.79  0.79  0.79  700.00 
12/19/2022 0.86  0.86  0.79  0.81  10,400 
12/16/2022 0.79  0.86  0.79  0.82  1,200 
12/15/2022 0.79  0.79  0.79  0.79  1.00 
12/14/2022 0.73  0.79  0.73  0.79  700.00 
12/13/2022 0.72  0.88  0.72  0.87  7,900 
12/12/2022 0.80  0.88  0.80  0.88  3,000 
12/09/2022 0.75  0.75  0.74  0.74  6,500 
12/08/2022 0.80  0.80  0.72  0.76  500.00 
12/07/2022 0.80  0.80  0.80  0.80  13,000 
12/06/2022 0.80  0.88  0.80  0.88  200.00 
12/05/2022 0.80  0.89  0.80  0.88  12,900 
12/02/2022 0.86  0.90  0.86  0.90  500.00 
12/01/2022 0.94  0.94  0.80  0.90  5,400 
11/30/2022 0.86  0.94  0.86  0.94  5,600 
11/29/2022 0.83  0.92  0.83  0.92  1,500 
11/28/2022 0.79  0.94  0.79  0.94  1,400 

About ImmunoCellular Therapeutics Pink Sheet history

ImmunoCellular Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ImmunoCellular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ImmunoCellular Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ImmunoCellular Therapeutics stock prices may prove useful in developing a viable investing in ImmunoCellular Therapeutics
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey. Immunocellular Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

ImmunoCellular Therapeutics Pink Sheet Technical Analysis

ImmunoCellular Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of ImmunoCellular Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ImmunoCellular Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

ImmunoCellular Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ImmunoCellular Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ImmunoCellular Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of ImmunoCellular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in ImmunoCellular Pink Sheet

If you are still planning to invest in ImmunoCellular Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoCellular Therapeutics' history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital